EpiCept Reports Positive Trial Results
Shares of EpiCept Corp. (EPCT) surged $1.67 to close at $3.95 after a compound showed promise treating brain tumors.
posted by FC Market News at 9:37 AM
Friday, April 20, 2007
Previous Posts
- Foot Locker To Buy Genesco
- Google Earnings Impress
- Smith Micro Software Downgraded
- Earnings Rise For Heatland Express
- Intersil's Earnings Rise
- Spansion Widens Losses
- Avici Swings To Profit
- Labor Ready Beats Estimates
- Buy Out Rumors Lift Jefferies Group
- Linear Technology Accelerates Stock Buy Back Plan
0 Comments:
Post a Comment
<< Home